CVS - CIK 0000064803
The table below shows CVS HEALTH Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B | $15.87B |
| Capital expenditure | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B | $2.44B |
| Investing cash flow | -$5.87B | -$7.61B | -$20.89B | -$5.05B | -$5.26B | -$5.53B |
| Dividends paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.63B |
CVS HEALTH Corp reported operating cash flow of $10.64B for fiscal year 2025. That is up 16.8% from $9.11B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $10.14B (FY 2016) to $10.64B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.62B |
| Stock buybacks | $0.00 | $3.02B | $2.01B | $3.50B | $0.00 | $0.00 |
| Financing cash flow | -$4.94B | -$1.14B | $2.68B | -$10.52B | -$11.36B | -$7.70B |